DUBLIN, May 14, 2018 /PRNewswire/ --
The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.
Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain. Neuropathic pain is not a single disease, but a syndrome caused by an array of different diseases and lesions, with common subtypes such as diabetic peripheral neuropathy, post-herpetic neuralgia, and chemotherapy-induced neuropathic pain.
Market Snapshot
- Treatment of neuropathic pain has remained stagnant over recent years due to lack of innovation within the pain market.
- The burden of neuropathic pain is difficult to estimate, but is likely high across all analyzed countries.
Key Topics Covered:
Treatment: Neuropathic Pain
- Overview
- Executive Summary
- Primary Research Methodology
- Disease Definition And Diagnosis
- Patient Segmentation
- Current Treatment Options
- Prescribing Trends
- Unmet Needs In Neuropathic Pain
Epidemiology: Neuropathic Pain
- Overview
- Disease Background
- Methodology
- Forecast
- Bibliography
For more information about this report visit https://www.researchandmarkets.com/research/7rlw24/global?w=5
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets